10% Owner Opaleye Management Sells $7.8M in Harrow Stock
HROW sits 75% above its 52-week low of $20.85 on elevated volume (3.1× avg).
Summary
Opaleye Management Inc., a 10% owner of Harrow, Inc., disposed of approximately $7.8 million worth of common stock in open market sales.
Key Events · Ownership and Investor Activity · HROW
-
10% Owner Sells Shares
Opaleye Management Inc., a significant institutional investor and 10% owner of Harrow, Inc., sold 198,572 shares of common stock.
-
Substantial Value Disposed
The total value of the shares sold was approximately $7.85 million, executed in open market transactions on March 3rd and 4th, 2026.
-
Timing Post-Positive News
This sale occurred immediately after Harrow, Inc. reported strong Q4 earnings and initiated a Phase 3 clinical trial, potentially signaling a lack of increased conviction despite recent positive developments.
Analysis · HROW · Life Sciences
This Form 4 filing reports a substantial open market sale of Harrow, Inc. common stock by Opaleye Management Inc., a 10% owner. The disposition of approximately $7.85 million in shares, representing 0.583% of the company's market capitalization, indicates a notable reduction in exposure by a significant institutional investor. While such sales by 10% owners can be for portfolio rebalancing, the timing, just days after the company reported strong Q4 earnings and initiated a Phase 3 clinical trial, could be viewed negatively by the market as it suggests a lack of increased conviction despite recent positive operational developments.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.2% of the 1581 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HROW was trading at $36.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $20.85 to $54.85. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.